AIDGenomics vs FORE Biotherapeutics
AIDGenomics vs FORE Biotherapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AIDGenomics is on 21/100 and FORE Biotherapeutics on 56/100.
Where each one leads
AIDGenomics
Leads on none of the measures we hold for both companies.
FORE Biotherapeutics
- our overall score: 56/100 against 21/100
- agent readiness: 37/100 against 21/100
- domain rating: 33/100 against 13/100
- LinkedIn following: 4,584 against 2,137
At a glance
| Measure | AIDGenomics | FORE Biotherapeutics |
|---|---|---|
| What it is | Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, Personalized, Next Generation Sequencing, HealthTech | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2014 | 2011 |
| Headquarters | Not published | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | AIDGenomics | FORE Biotherapeutics |
|---|---|---|
| Employees | 46 | 56 |
| Headcount growthLast 12 months | +7.0% | +8.2% |
| Total funding | Not published | $232M |
| Latest round | Bootstrapped | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 2,137 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AIDGenomics | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 21/100 | 56/100 |
| Traction | 17/100 | 58/100 |
| Team | Not published | 70/100 |
| Search visibility | 34/100 | 38/100 |
| Quality | Not published | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AIDGenomics | FORE Biotherapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
AIDGenomics vs FORE Biotherapeutics: common questions
Which is better, AIDGenomics or FORE Biotherapeutics?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 21/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do AIDGenomics and FORE Biotherapeutics compare on the numbers?
FORE Biotherapeutics leads on our overall score (56/100 against 21/100), agent readiness (37/100 against 21/100), domain rating (33/100 against 13/100), LinkedIn following (4,584 against 2,137).
Read the full AIDGenomics review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other AIDGenomics alternatives we track.